blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4065111

EP4065111 - POTENT AND SELECTIVE AZAINDOLE INHIBITORS OF CDK8 AND CDK19 [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  02.09.2022
Database last updated on 31.08.2024
FormerThe international publication has been made
Status updated on  04.06.2021
Most recent event   Tooltip01.03.2024Amendment by applicant 
Applicant(s)For all designated states
Dana-Farber Cancer Institute, Inc.
450 Brookline Avenue
Boston, Massachusetts 02215 / US
[2022/40]
Inventor(s)01 / GRAY, Nathanael S.
26 Greenview Avenue
Boston, Massachusetts 02130 / US
02 / HATCHER, John M.
2 Glover Court
BOSTON, Massachusetts 02127 / US
03 / SREEVATSAN, Prasanna
275 Main Street, Apt. 702
Watertown, Massachusetts 02472 / US
 [2022/40]
Representative(s)Heller, Benjamin Henry, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2022/40]
Application number, filing date20893666.625.11.2020
[2022/40]
WO2020US62264
Priority number, dateUS201962940632P26.11.2019         Original published format: US 201962940632 P
[2022/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021108581
Date:03.06.2021
Language:EN
[2021/22]
Type: A1 Application with search report 
No.:EP4065111
Date:05.10.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 03.06.2021 takes the place of the publication of the European patent application.
[2022/40]
Search report(s)International search report - published on:US03.06.2021
(Supplementary) European search report - dispatched on:EP18.08.2023
ClassificationIPC:C07D519/00, A61K31/437, A61P25/28, A61P35/00
[2023/38]
CPC:
C07D519/00 (EP,US); A61P25/28 (EP); A61P35/00 (EP);
C07D471/04 (US); C07D487/04 (US); C07D495/04 (US)
Former IPC [2022/40]A61K31/437, C07D471/04, C07D401/14
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/40]
TitleGerman:HOCHWIRKSAME UND SELEKTIVE AZAINDOLINHIBITOREN VON CDK8 UND CDK19[2022/40]
English:POTENT AND SELECTIVE AZAINDOLE INHIBITORS OF CDK8 AND CDK19[2022/40]
French:INHIBITEURS AZAINDOLIQUES PUISSANTS ET SÉLECTIFS DE CDK8 ET CDK19[2022/40]
Entry into regional phase20.06.2022National basic fee paid 
20.06.2022Search fee paid 
20.06.2022Designation fee(s) paid 
20.06.2022Examination fee paid 
Examination procedure20.06.2022Examination requested  [2022/40]
29.02.2024Amendment by applicant (claims and/or description)
29.02.2024Date on which the examining division has become responsible
Fees paidRenewal fee
28.11.2022Renewal fee patent year 03
27.11.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]  - AURÉLIE MALLINGER ET AL, "Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19", JOURNAL OF MEDICINAL CHEMISTRY, US, (20160211), vol. 59, no. 3, doi:10.1021/acs.jmedchem.5b01685, ISSN 0022-2623, pages 1078 - 1101, XP055336343 [A] 1-15 * table 5; compound 3 *

DOI:   http://dx.doi.org/10.1021/acs.jmedchem.5b01685
International search[Y]US2011195951  (GRACZYK PIOTR PAWEL [GB], et al) [Y] 16 * abstract; para [0072] *;
 [A]US2011201599  (BAHCECI SULEYMAN [US], et al) [A] 1-3, 5-8, 14-16; 18 * ENTIRE DOCUMENT *;
 [A]US2017027956  (HOPKINS BRIAN T [US], et al) [A] 1-3, 5-8, 14-16; 18* ENTIRE DOCUMENT *;
 [XY]US2018215763  (WU GUOXIAN [US], et al) [X] 1-3; 5-8, 14; 15; 18 * para [0002]; pg. 136, Table 1; pg. 151, Table 1 * [Y] 16
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.